carumonam has been researched along with Pseudomonas-Infections* in 2 studies
2 other study(ies) available for carumonam and Pseudomonas-Infections
| Article | Year |
|---|---|
In vitro activities of Ro 17-2301 and aztreonam compared with those of other new beta-lactam antibiotics against clinical isolates of Pseudomonas aeruginosa.
The in vitro activities of Ro 17-2301 and aztreonam against 191 Pseudomonas aeruginosa isolates were compared with those of five other beta-lactam antibiotics. Both compounds showed activities comparable to that of ceftazidime and were bactericidal. They were as effective against gentamicin-or carbenicillin-resistant isolates as against susceptible ones. Topics: Anti-Bacterial Agents; Aztreonam; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 1985 |
In-vitro activity of the monobactam Ro 17-2301 against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa.
Ro 17-2301 is a monobactam antibiotic. Its in-vitro activity was compared with those of aztreonam, ampicillin, cefuroxime, ceftriaxone, ceftazidime, and gentamicin. Ro 17-2301 had qualitatively similar activity to aztreonam and activity superior to that all the other antibiotics against the Enterobacteriaceae, but against Pseudomonas aeruginosa ceftazidime had equal or marginally better activity. Topics: Anti-Bacterial Agents; Aztreonam; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 1985 |